← Back to Clinical Trials
Recruiting NCT06519136

NCT06519136 The Effect of Second Level Reiki on Pain Severity and Quality of Life in Patients Receiving Hemodialysis Treatment

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06519136
Status Recruiting
Phase
Sponsor Mersin University
Condition Hemodialysis
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2024-10-01
Primary Completion 2024-10-28

Eligibility & Interventions

Sex All sexes
Min Age 28 Years
Max Age 84 Years
Study Type INTERVENTIONAL
Interventions
Distance ReikiSham Reiki

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2024-10-01 with a primary completion date of 2024-10-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Purpose: The aim of this study is to determine the effect of 20-minute second-level Reiki application for 4 consecutive days on pain intensity and quality of life in patients receiving hemodialysis (HD) treatment and It is a comparison of the follow-up results of the first level Reiki applied within the scope of the doctoral thesis and the second level Reiki applications to be applied within the scope of this study. Method: The study will be conducted as a pre-test-post-test, double-blind, randomized controlled trial. After obtaining Ethical Committee approval, participants in the Reiki group will receive 20-minute Reiki sessions at the second level daily from 7:00 PM to 9:00 PM for four days, while participants in the sham Reiki group will be informed that distant energy application will be performed but no actual treatment will be administered. The researcher will plan to administer second-level Reiki sessions to 8 patients daily. Throughout the study, patients in both groups will continue their routine treatments. At the beginning and three weeks after the end of the intervention, Kidney Disease Quality of Life Scale (KDQOLTM-36) scores will be collected face-to-face at HD centers, before and after the intervention Visual Analog Scale for Pain (VAS-Pain), additionally, psychodynamic responses experienced during the first and last Reiki sessions will be evaluated by three blinded assessors via telephone in both study groups. Results: Statistical analyses of the data will be conducted using the Statistical Package for Social Sciences (Version 22.0, SPSS Inc., Chicago, IL, USA, License: Hitit University). Depending on the homogeneity of the data distribution, appropriate parametric or nonparametric tests will be performed for data evaluation.

Eligibility Criteria

Inclusion Criteria: * Patients who volunteered to participate in the research and received first level Reiki within the scope of the study titled "The effect of Reiki application on pain severity and quality of life in patients receiving hemodialysis treatment", * In patients over 65 years of age, patients with a Standardized Mini Mental Test (SMMT) score of 24 points and above will be included in the sample. Exclusion Criteria: * Those who do not volunteer to participate in the research, * Deceased, * Changing the treatment center, * Starting to receive peritoneal dialysis treatment or having renal transplantation, * Using another complementary integrative therapy application, * In patients over 65 years of age, patients with an SMMT value below 24 will not be included in the sample.

Contact & Investigator

Central Contact

Sultan Çeçen

✉ sultancecen@hitit.edu.tr

📞 +90 364 223 15 61

Frequently Asked Questions

Who can join the NCT06519136 clinical trial?

This trial is open to participants of all sexes, aged 28 Years or older, up to 84 Years, studying Hemodialysis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06519136 currently recruiting?

Yes, NCT06519136 is actively recruiting participants. Contact the research team at sultancecen@hitit.edu.tr for enrollment information.

Where is the NCT06519136 trial being conducted?

This trial is being conducted at Çorum, Turkey (Türkiye).

Who is sponsoring the NCT06519136 clinical trial?

NCT06519136 is sponsored by Mersin University. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology